UBS Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-119,798
Closed -$11.1M 10162
2021
Q4
$11.1M Buy
119,798
+63,121
+111% +$5.87M ﹤0.01% 1480
2021
Q3
$3.38M Buy
56,677
+42,402
+297% +$2.52M ﹤0.01% 2361
2021
Q2
$973K Sell
14,275
-40,157
-74% -$2.74M ﹤0.01% 3272
2021
Q1
$3.78M Buy
54,432
+25,346
+87% +$1.76M ﹤0.01% 2208
2020
Q4
$2.23M Buy
29,086
+11,667
+67% +$896K ﹤0.01% 2554
2020
Q3
$1.3M Buy
17,419
+360
+2% +$26.9K ﹤0.01% 2753
2020
Q2
$1.07M Sell
17,059
-19,123
-53% -$1.2M ﹤0.01% 2767
2020
Q1
$1.52M Buy
36,182
+10,496
+41% +$441K ﹤0.01% 2378
2019
Q4
$1.17M Sell
25,686
-45,621
-64% -$2.07M ﹤0.01% 3196
2019
Q3
$3.26M Buy
71,307
+47,728
+202% +$2.18M ﹤0.01% 2196
2019
Q2
$1.38M Sell
23,579
-1,219
-5% -$71.5K ﹤0.01% 2794
2019
Q1
$1.11M Sell
24,798
-60,009
-71% -$2.69M ﹤0.01% 2851
2018
Q4
$3.3M Buy
84,807
+28,444
+50% +$1.11M ﹤0.01% 2027
2018
Q3
$2.59M Buy
56,363
+26,037
+86% +$1.2M ﹤0.01% 2421
2018
Q2
$1.32M Sell
30,326
-102,921
-77% -$4.49M ﹤0.01% 2855
2018
Q1
$5.26M Buy
133,247
+100,081
+302% +$3.95M ﹤0.01% 1812
2017
Q4
$1.13M Sell
33,166
-7,740
-19% -$263K ﹤0.01% 2946
2017
Q3
$1.04M Buy
40,906
+38,007
+1,311% +$969K ﹤0.01% 2975
2017
Q2
$49K Sell
2,899
-311
-10% -$5.26K ﹤0.01% 4746
2017
Q1
$47K Sell
3,210
-6,900
-68% -$101K ﹤0.01% 4678
2016
Q4
$144K Buy
10,110
+3,483
+53% +$49.6K ﹤0.01% 4150
2016
Q3
$116K Buy
6,627
+730
+12% +$12.8K ﹤0.01% 4074
2016
Q2
$101K Buy
5,897
+374
+7% +$6.41K ﹤0.01% 4197
2016
Q1
$109K Sell
5,523
-32,404
-85% -$640K ﹤0.01% 4172
2015
Q4
$721K Buy
37,927
+33,554
+767% +$638K ﹤0.01% 2907
2015
Q3
$84K Buy
4,373
+257
+6% +$4.94K ﹤0.01% 4326
2015
Q2
$191K Sell
4,116
-3,486
-46% -$162K ﹤0.01% 3907
2015
Q1
$332K Buy
7,602
+1,272
+20% +$55.6K ﹤0.01% 3473
2014
Q4
$220K Buy
+6,330
New +$220K ﹤0.01% 3722